Publicaciones Científicas

The Use of 2 e-Learning Modalities for Diabetes Education Using Facebook in 2 Cities of Argentina During the COVID-19 Pandemic: Qualitative Study

D. L. Moyano,M. V. Lopez,A. Cavallo,J. P. Candia,A. Kaen,V. Irazola and A. Beratarrechea. The Use of 2 e-Learning Modalities for Diabetes Education Using Facebook in 2 Cities of Argentina During the COVID-19 Pandemic: Qualitative Study. JMIR Form Res. 2022;6(11):10.2196/38862.

The Use of 2 e-Learning Modalities for Diabetes Education Using Facebook in 2 Cities of Argentina During the COVID-19 Pandemic: Qualitative Study Ver más »

The quality of clinical practice guidelines for preoperative care using the AGREE II instrument: a systematic review

A. Ciapponi,E. Tapia-López,S. Virgilio and A. Bardach. The quality of clinical practice guidelines for preoperative care using the AGREE II instrument: a systematic review. Syst Rev. 2020;9(1):10.1186/s13643-020-01404-8.

The quality of clinical practice guidelines for preoperative care using the AGREE II instrument: a systematic review Ver más »

The Ottawa Statement on the ethical design and conduct of cluster randomised trials: precis for researchers and research ethics committees

M. Taljaard,C. Weijer,J. M. Grimshaw and M. P. Eccles. The Ottawa Statement on the ethical design and conduct of cluster randomised trials: precis for researchers and research ethics committees. Bmj. 2013;346:10.1136/bmj.f2838.

The Ottawa Statement on the ethical design and conduct of cluster randomised trials: precis for researchers and research ethics committees Ver más »

The need for standardized reporting of research findings in the field of quality of care

E. García-Elorrioand S. Aziz. The need for standardized reporting of research findings in the field of quality of care. Int J Qual Health Care. 2021;33(1):10.1093/intqhc/mzab040.

The need for standardized reporting of research findings in the field of quality of care Ver más »

The Moderate Alcohol and Cardiovascular Health Trial (MACH15): Design and methods for a randomized trial of moderate alcohol consumption and cardiometabolic risk

D. Spiegelman,L. C. Lovato,P. Khudyakov,T. L. Wilkens,C. A. Adebamowo,S. N. Adebamowo,L. J. Appel,J. W. Beulens,J. W. Coughlin,L. O. Dragsted,H. J. Edenberg,J. N. Eriksen,R. Estruch,D. E. Grobbee,P. E. Gulayin,V. Irazola,J. H. Krystal,M. Lazo,M. M. Murray,E. B. Rimm,I. C. Schrieks,J. D. Williamson and K. J. Mukamal. The Moderate Alcohol and Cardiovascular Health Trial (MACH15): Design and methods for a randomized trial of moderate alcohol consumption and cardiometabolic risk. Eur J Prev Cardiol. 2020;27(18):10.1177/2047487320912376.

The Moderate Alcohol and Cardiovascular Health Trial (MACH15): Design and methods for a randomized trial of moderate alcohol consumption and cardiometabolic risk Ver más »

The Kathmandu Declaration on Global CVD/Hypertension Research and Implementation Science: A Framework to Advance Implementation Research for Cardiovascular and Other Noncommunicable Diseases in Low- and Middle-Income Countries

A. Aifah,J. Iwelunmor,C. Akwanalo,J. Allison,A. Amberbir,K. P. Asante,A. Baumann,A. Brown,M. Butler,M. Dalton,V. Davila-Roman,A. L. Fitzpatrick,M. Fort,R. Goldberg,A. Gondwe,D. Ha,J. He,M. Hosseinipour,V. Irazola,J. Kamano,S. Karengera,B. M. Karmacharya,R. Koju,R. Maharjan,S. Mohan,V. Mutabazi,E. Mutimura,A. Muula,K. M. V. Narayan,H. Nguyen,B. Njuguna,M. Nyirenda,G. Ogedegbe,J. van Oosterhout,D. Onakomaiya,S. Patel,A. Paniagua-Ávila,M. Ramirez-Zea,J. Plange-Rhule,D. Roche,A. Shrestha,H. Sharma,N. Tandon,N. Thu-Cuc,A. Vaidya,R. Vedanthan and M. B. Weber. The Kathmandu Declaration on Global CVD/Hypertension Research and Implementation Science: A Framework to Advance Implementation Research for Cardiovascular and Other Noncommunicable Diseases in Low- and Middle-Income Countries. Glob Heart. 2019;14(2):10.1016/j.gheart.2019.05.006.

The Kathmandu Declaration on Global CVD/Hypertension Research and Implementation Science: A Framework to Advance Implementation Research for Cardiovascular and Other Noncommunicable Diseases in Low- and Middle-Income Countries Ver más »

The impact of hydroxychloroquine on obstetric outcomes in refractory obstetric antiphospholipid syndrome

M. Gerde,E. Ibarra,R. Mac Kenzie,C. Fernandez Suarez,C. Heer,R. Alvarez,M. Iglesias,J. Balparda,E. Beruti and F. Rubinstein. The impact of hydroxychloroquine on obstetric outcomes in refractory obstetric antiphospholipid syndrome. Thrombosis Research. 2021;206:10.1016/j.thromres.2021.08.004.

The impact of hydroxychloroquine on obstetric outcomes in refractory obstetric antiphospholipid syndrome Ver más »